piperidine-based CCR1 antagonists (Berlex)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepiperidine-based CCR1 antagonists (Berlex)
Drug Alias NameBX-471 follow-up compounds (Berlex)CCR1 antagonists (Berlex)BX-510BX-511BX-513
ClassificationSmall molecules
Mechanisms of ActionC-C chemokine receptor type 1 antagonists
TargetsC-C chemokine receptor type 1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBerlex Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBerlex Biosciences Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A